GRCE · Grace Therapeutics, Inc.
$2.43
+0.00 (+0.00%)
At close · Jul 21
Market Cap
$38.81M
Shares
16.27M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Prashant Kohli | CEO | $1,074,621 |
| Amresh Kumar | Vice President, Program Management | $421,563 |
| Carrie D’Andrea | Vice President, Clinical Operations | $421,563 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Prashant Kohli | CEO | $987,630 |
| Carrie D’Andrea | Vice President, Clinical Operations | $383,000 |
| Amresh Kumar | Vice President, Program Management | $378,019 |